BACKGROUND: Primary percutaneous coronary intervention (PCI) is shown to be the most effective reperfusion strategy in acute myocardial infarction. The aim of this multicentre national randomized mortality trial was to test whether the nationwide change in treatment guidelines (transportation of all patients to PCI centres) was warranted. METHODS: The PRAGUE-2 study randomized 850 patients with acute ST elevation myocardial infarction presenting within <12 h to the nearest community hospital without a catheter laboratory to either thrombolysis in this hospital (TL group, n=421) or immediate transport for primary percutaneous coronary intervention (PCI group, n=429). The primary end-point was 30-day mortality. Secondary end-points were: death/reinfarction/stroke at 30 days (combined end-point) and 30-day mortality among patients treated within 0-3 h and 3-12 h after symptom onset. Maximum transport distance was 120 km. RESULTS: Five complications (1.2%) occurred during the transport. Randomization-balloon time in the PCI group was 97+/-27 min, and randomization-needle time in the TL group was 12+/-10 min. Mortality at 30 days was 10.0% in the TL group compared to 6.8% mortality in the PCI group (P=0.12, intention-to-treat analysis). Mortality of 380 patients who actually underwent PCI was 6.0% vs 10.4% mortality in 424 patients who finally received TL (P<0.05). Among 299 patients randomized >3 h after the onset of symptoms, the mortality of the TL group reached 15.3% compared to 6% in the PCI group (P<0.02). Patients randomized within <3 h of symptom onset (n=551) had no difference in mortality whether treated by TL (7.4%) or transferred to PCI (7.3%). A combined end-point occurred in 15.2% of the TL group vs 8.4% of the PCI group (P<0.003). CONCLUSIONS: Long distance transport from a community hospital to a tertiary PCI centre in the acute phase of AMI is safe. This strategy markedly decreases mortality in patients presenting >3 h after symptom onset. For patients presenting within <3 h of symptoms, TL results are similar results to long distance transport for PCI.

Cardiocenter Vinohardy Prague Czech Republic

Komentář v

Eur Heart J. 2003 Jan;24(1):21-3. doi: 10.1016/s0195-668x(02)00693-0. PubMed

Komentář v

Eur Heart J. 2003 Oct;24(19):1798. doi: 10.1016/j.ehj.2003.06.001. PubMed

Komentář v

Eur Heart J. 2003 Nov;24(22):2071; author reply 2071-2. doi: 10.1016/j.ehj.2003.05.001. PubMed

Citace poskytuje Crossref.org

Primary percutaneous coronary intervention is appropriate in transient ST-elevation myocardial infarction

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials

Risk Stratification of Patients with Acute Coronary Syndrome

In Comparison to Pathological Q Waves, Selvester Score is a Superior Diagnostic Indicator of Increased Long-Term Mortality Risk in ST Elevation Myocardial Infarction Patients Treated with Primary Coronary Intervention

Higher incidence of hypotension episodes in women during the sub-acute phase of ST elevation myocardial infarction and relationship to covariates

Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences

Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry

Stent for Life Initiative: where are we standing and where are we going?

How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?

Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries

Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies

Myocardial ischemic injury and protection